I thank Mark Isherwood for raising that important point and, certainly, I will go away and look at what is causing that delay in those health boards. So, thank you for raising that. 

I would point, as I think David Rees highlighted as well, to the fact that the single cancer pathway is the standout achievement, a platform for improvement that is unique in the UK. But I would also point to the development of a new cancer informatics system, to our investment in new radiotherapy equipment, the impact of the new treatment fund, and many more things beside. Perhaps most of all, I should point out the dedication and professionalism of our managerial and clinical staff, who work day in and day out to provide excellent patient care. 

I think the important point in terms of today's debate is that we ensure that we build on the success and momentum built up in recent years—a lot has been done, but there's a lot more to do—that we realise the potential of what has been developed through the cancer delivery plan, and we go even harder at the systemic issues that hold back our cancer outcomes. This means, as has been repeated in this debate: prevention, earlier detection, high-quality care, better service planning and workforce provision, as well as new service models and harnessing the potential of geonomics, digital and research. 

So, the Minister and I do look forward to updating Members further on progress later in the year, but once again thank you very much for bringing forward this debate to give us the opportunity to discuss these very important issues.